Company: RGNT
Filing Date: 2025-02-12
Form Type: DRS/A
Source: 0001213900-25-012299
Chunk: 215

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-02-12
Form: DRS/A
Chunk 215
---
 Shares by a shareholder who is a U.S. resident
(for purposes of the United States-Israel Tax Treaty) holding the Ordinary Shares as a capital asset and is entitled to claim the benefits
under the United States-Israel Tax Treaty, or a U.S. Treaty Resident, is generally exempt from Israeli capital gains tax unless, among
other things: (i) the U.S. Treaty Resident is an individual who was present in Israel for 183 days or more in the aggregate during the
relevant tax year; or (ii) such U.S. Treaty Resident holds, directly or indirectly, shares representing 10% or more of our voting power
of the Company during any part of the 12 month period preceding such sale, exchange or disposition, subject to certain conditions. In
any such case (unless determined otherwise by the Israeli tax legislation regarding exemptions for non-Israeli residents as mentioned
above), the sale, exchange or disposition of our Ordinary Shares would be subject to Israeli tax, at the applicable rate. However, under
the United States-Israel Tax Treaty, such U.S. Treaty Resident would be permitted to claim tax credit for U.S. federal income tax imposed
on any gain from such sale, exchange or disposition, under the circumstances and subject to the limitations specified in the United States-Israel
Income Tax Treaty.

Regardless of whether shareholders
may be liable for Israeli income tax on the sale of our Ordinary Shares, the payment of the consideration may be subject to withholding
of Israeli tax at the source. Accordingly, shareholders may be required to present an appropriate pre-approval by the Israel Tax Authority
that they are exempt from tax on their capital gains in order to avoid withholding at source at the time of sale. More Specifically,
in transactions involving a sale of all of the shares of an Israeli resident company, in the form of a merger or otherwise, the Israel
Tax Authority may require from shareholders who are not liable for Israeli tax to declare so or obtain a specific exemption from the
Israel Tax Authority to confirm their status as non-Israeli resident, and, in the absence of such declarations or exemptions, they may
require the purchaser of the shares to withhold taxes at source in the applicable rates.

Surtax

Subject to the provisions
of any applicable tax treaty, individuals who are subject to tax in Israel (whether or not any such individual is an Israeli resident)
are also subject to a surtax at the rate of 3% on annual income (including, but not limited to, dividends, interest and capital gains)
ex